Bengaluru-based startup Plazza is in advanced discussions to raise around $15 million in a new funding round, as it looks to aggressively scale its hyperlocal medicine delivery model. The round underscores growing investor interest in blending quick commerce with healthcare — a space that is still evolving but rapidly gaining traction.
Sources indicate that leading venture capital firms including Accel, Elevation Capital, and Nexus Venture Partners are expected to contribute roughly $4 million each. Existing investor All In Capital is also likely to participate, contributing the remaining $3 million.
If finalized, the round could value Plazza at approximately $50 million, marking a significant jump for the young startup.
Credits: Indian Food Times
A Rapid Follow-On After Seed Success
What makes this fundraise particularly notable is its timing. Plazza had raised just $1.4 million in a seed round in September last year, led by All In Capital with participation from Better Capital and several angel investors.
That capital was primarily deployed to expand its product catalogue and strengthen operations in Bengaluru. The company operates through a hybrid model combining physical retail outlets with app-based ordering, allowing it to control both inventory and delivery timelines.
The swift follow-on round suggests strong early traction and investor belief in the startup’s execution capabilities. At the same time, it also reflects the capital-intensive nature of the business, where speed and reliability require significant infrastructure investment.
Inside Plazza’s Hyperlocal Fulfilment Model
At the core of Plazza’s strategy is a quick commerce-like approach tailored for pharmaceuticals. The startup promises medicine deliveries within 15 to 60 minutes — a sharp contrast to traditional e-pharmacy models that often take hours or even days.
Unlike marketplace-based competitors, Plazza operates an inventory-led model. It stocks medicines and healthcare products across its own network of stores, which function similarly to dark stores used in grocery delivery.
The company currently offers over 20,000 SKUs — significantly more than a typical neighbourhood pharmacy — and has served over 10,000 customers so far. With weekly growth estimated at around 25 percent, the startup is now gearing up for its next phase of expansion.
As part of its growth plans, Plazza aims to open around 20 new outlets over the next 12 months, further strengthening its hyperlocal footprint.
A Crowded and Evolving Market
Plazza’s expansion comes at a time when multiple players are eyeing the intersection of quick commerce and healthcare. Established platforms are already testing or scaling similar offerings.
For instance, Swiggy Instamart has partnered with PharmEasy to deliver medicines, while Zepto has reportedly been exploring direct medicine delivery options.
Meanwhile, Amazon India continues to expand its healthcare ecosystem through pharmacy and diagnostics integrations.
This growing competition highlights both the opportunity and the challenges in the segment, where customer expectations around speed, availability, and reliability are rising quickly.
High Stakes, High Capital
While the opportunity in instant medicine delivery is vast, it comes with its own complexities. Unlike grocery delivery, pharmaceuticals operate within a tightly regulated framework, requiring compliance with multiple legal and safety standards.
Additionally, the inventory-led model means higher upfront costs, including warehousing, cold storage (for certain medicines), and supply chain management. Expanding store networks further adds to operational expenses.
The planned $15 million raise is expected to help Plazza address these challenges by scaling its store footprint, deepening inventory, and investing in backend logistics and supply chain capabilities.
Credits: Moneycontrol
The Road Ahead
Plazza is positioning itself at the convergence of two high-growth sectors — quick commerce and digital healthcare. Its focus on speed and reliability could offer a strong competitive edge, especially in urgent healthcare scenarios where time is critical.
However, sustaining this model will require careful execution, strong unit economics, and the ability to navigate regulatory complexities.
For now, the startup appears to be doubling down on its core promise: delivering medicines as quickly and seamlessly as ordering groceries — a proposition that could redefine how healthcare is accessed in urban India.
